Improving Mycobacterium bovis Bacillus Calmette-Guèrin as a Vaccine Delivery Vector for Viral Antigens by Incorporation of Glycolipid Activators of NKT Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improving Mycobacterium bovis Bacillus Calmette-Guèrin as a Vaccine Delivery Vector for Viral Antigens by Incorporation of Glycolipid Activators of NKT Cells
Authors
Keywords
T cells, Glycolipids, Cytotoxic T cells, Mouse models, Immunologic adjuvants, Antigens, SIV, Vaccines
Journal
PLoS One
Volume 9, Issue 9, Pages e108383
Publisher
Public Library of Science (PLoS)
Online
2014-09-26
DOI
10.1371/journal.pone.0108383
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Single Subset of Dendritic Cells Controls the Cytokine Bias of Natural Killer T Cell Responses to Diverse Glycolipid Antigens
- (2014) Pooja Arora et al. IMMUNITY
- Natural killer T cell anergy, co-stimulatory molecules and immunotherapeutic interventions
- (2013) Avadhesh Kumar Singh et al. HUMAN IMMUNOLOGY
- Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization
- (2013) K. M. Quinn et al. JOURNAL OF IMMUNOLOGY
- A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+ T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates
- (2013) Neal N. Padte et al. PLoS One
- Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells
- (2013) X. Wen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
- (2011) Richard Hopkins et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NKT TCR Recognition of CD1d- -C-Galactosylceramide
- (2011) O. Patel et al. JOURNAL OF IMMUNOLOGY
- A Rapid Fluorescence-Based Assay for Classification of iNKT Cell Activating Glycolipids
- (2011) Pooja Arora et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy
- (2011) T.-N. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant
- (2010) Neal N. Padte et al. CLINICAL IMMUNOLOGY
- Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector
- (2010) Rosamund Chapman et al. CURRENT HIV RESEARCH
- Synthetic iNKT cell-agonists as vaccine adjuvants—finding the balance
- (2010) Vincenzo Cerundolo et al. CURRENT OPINION IN IMMUNOLOGY
- Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques
- (2010) Maximillian Rosario et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens
- (2010) Luc Van Kaer et al. Immunotherapy
- Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant
- (2010) X. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Harnessing human CD1d restricted T cells for tumor immunity: progress and challenges
- (2009) Madhav et al. Frontiers in Bioscience-Landmark
- Kinetics and Cellular Site of Glycolipid Loading Control the Outcome of Natural Killer T Cell Activation
- (2009) Jin S. Im et al. IMMUNITY
- Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells
- (2009) Xiangming Li et al. IMMUNOLOGY
- Invariant TCR Rather Than CD1d Shapes the Preferential Activities of C-Glycoside Analogues Against Human Versus Murine Invariant NKT Cells
- (2009) X. Li et al. JOURNAL OF IMMUNOLOGY
- Incorporation of NKT Cell-Activating Glycolipids Enhances Immunogenicity and Vaccine Efficacy of Mycobacterium bovis Bacillus Calmette-Guerin
- (2009) M. M. Venkataswamy et al. JOURNAL OF IMMUNOLOGY
- Recombinant Mycobacterium bovis BCG Prime-Recombinant Adenovirus Boost Vaccination in Rhesus Monkeys Elicits Robust Polyfunctional Simian Immunodeficiency Virus-Specific T-Cell Responses
- (2009) M. J. Cayabyab et al. JOURNAL OF VIROLOGY
- Reducing the Activity and Secretion of Microbial Antioxidants Enhances the Immunogenicity of BCG
- (2009) Shanmugalakshmi Sadagopal et al. PLoS One
- Adjuvant activity mediated by iNKT cells
- (2009) Shinichiro Fujii et al. SEMINARS IN IMMUNOLOGY
- Lipid and glycolipid antigens of CD1d-restricted natural killer T cells
- (2009) Manjunatha M. Venkataswamy et al. SEMINARS IN IMMUNOLOGY
- Evasion and subversion of antigen presentation byMycobacterium tuberculosis
- (2009) A. Baena et al. TISSUE ANTIGENS
- Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
- (2009) Ronggai Sun et al. VACCINE
- Recombinant Mycobacterium bovis BCG
- (2009) Reginaldo G. Bastos et al. VACCINE
- Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, α-galactosylceramide
- (2008) Yaoxing Huang et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started